Certolizumab pegol, a pegylated anti-TNF-α antagonist, caused de novo-
onset palmoplantar pustulosis followed by generalized pustular psoriasis in a patient with rheumatoid arthritis
Certolizumab pegol, a pegylated anti-TNF-α antagonist, caused de novo-
onset palmoplantar pustulosis followed by generalized pustular psoriasis in a patient with rheumatoid arthritis
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search